SlideShare a Scribd company logo
1 of 1
RESULTS
Demonstrate Quantification of Cell
Movement
Comparing images, the distance of the
leading cell in each channel from the cell
reservoir was measured (Figure 3).
 No cell response observed in standard
media.
 Some migration observed in cells with
conditioned media (Figure 4).
 Highest migration observed with the
reagent side containing conditioned media.
Results indicated that the media conditioned
with SaOs-2 acted as a chemoattractant
(Figure 5).
sylvia.loh@mavs.uta.edu
ABSTRACT
Monitoring the migration of cancer cells,
metastasis can be better understood using
microfluidics.
 Metastasis of cancer is organ specific:
 Prostate cancer moves to the bone
and lungs.
 Breast cancer moves to the bone.
In this work, we assess the impact of
conditioned media on cell migration as a
model for metastasis of cancer.
INTRODUCTION
The American Cancer Society estimated:
 1 in 6 men will develop prostate
cancer.
 1 in 8 women will develop breast
cancer.
Microfluidics provide a(n):
 Ability to monitor cells.
 Accurate quantification of cell migration.
 Microenvironment for precise gradients.
MATERIALS AND METHODS
 Fabricated with poly-dimethylsiloxane
(PDMS).
 Consisted of a cell and a reagent
reservoir.
 Ten microchannels (10 μm in height, 25
μm in width and 1,000 μm in length)
connected the reservoirs.
 Contained 32 devices (Figure 1).
EXPERIMENT SETTING
 Prostate cancer (PC-3) cells were
transfected with green fluorescent
protein (Figure 2).
 The cells were cultured with standard
RPMI or conditioned media from SaOs-2
cells.
 Cells were seeded in cell reservoir at
3×103 in 50 μL of media and incubated.
 Equal volume of reagent was added to
the other reservoir.
 Images were captured at designated 24
hour intervals using a Nikon Ti Eclipse
microscope.
Microfluidics: An innovative approach in Monitoring Cancer Metastasis
Sylvia Loh, Junior, Biology/Bioengineering
Advisors: Smitha Rao and J. –C. Chiao
SUMMARY
Microfluidic Devices for Cell Migration
 Physical confinement to cells at a micro-
scale level for the movement.
 Controllable microenvironment for
chemogradients, time, and temperature.
 Allows recovery of cells for downstream
analyses.
 Validating the results and collecting
quantitative data.
 Work in Progress.
Figure 1: Microfluidic device mounted on a culture plate
A B C D
ACKNOWLEDGEMENTS
This work was supported by National
Institutes of Health (NIH) National Cancer
Institute grant R15CA133623, North Texas
Cancer Research Foundation and TxMRC.
Figure 2: PC3 cells transfected with GFP (green
fluorescent protein) in a cell reservoir under Brightfield
microscope and ultraviolet light
Brightfield UV
Figure 4: Microchannels containing cells with
conditioned media, showing migration
Figure 5: Measurement of migration of PC-3 cells with
and without SaOs-2 conditioned media against
standard media or SaOs-2 conditioned media
0
2
4
6
8
10
12
14
16
18
Media vs.
Media
Media vs.
Conditioned
Conditioned
vs. Media
Conditioned
vs.
Conditioned
Migrationdistance(μm)
Day 1
Day 2
Day 3
Day 4
Day 5
Figure 3: Migration of a PC-3 cell in RPMI in a single
channel over a 5 day period with SaOs2 conditioned
media as attraction
Day 1 - 31.39 μm
Day 2 - 203.16 μm
Day 3 - 283.51 μm
Day 4 - 285.37 μm
Day 5 - 290.05 μm

More Related Content

What's hot

SCT60103 Group 2 Presentation
SCT60103 Group 2 PresentationSCT60103 Group 2 Presentation
SCT60103 Group 2 PresentationJayden On
 
Compartment specific micro rna expression profiles (poster) poster
Compartment specific micro rna expression profiles (poster) posterCompartment specific micro rna expression profiles (poster) poster
Compartment specific micro rna expression profiles (poster) posterJackie Lau
 
American gut microbiome-2
American gut microbiome-2American gut microbiome-2
American gut microbiome-2JaclynW
 
Introduction to cancer bioinformatics
Introduction to cancer bioinformaticsIntroduction to cancer bioinformatics
Introduction to cancer bioinformaticscreativebiolabs11
 
Availability of Morphologically Similar, Genetically Diverge Penaeus Monodon ...
Availability of Morphologically Similar, Genetically Diverge Penaeus Monodon ...Availability of Morphologically Similar, Genetically Diverge Penaeus Monodon ...
Availability of Morphologically Similar, Genetically Diverge Penaeus Monodon ...Conferenceproceedings
 
biochem of cancer modified dialysis treatment
biochem of cancer modified dialysis treatmentbiochem of cancer modified dialysis treatment
biochem of cancer modified dialysis treatmentThomas Brinkman
 
Animal models in developmental therapeitocs
Animal models in developmental therapeitocsAnimal models in developmental therapeitocs
Animal models in developmental therapeitocsDr.Bhavin Vadodariya
 
Role of biotechnology in cancer control
Role of biotechnology in cancer controlRole of biotechnology in cancer control
Role of biotechnology in cancer controlJanani Gopalarethinam
 
SCT60103 - Chemotherapy
SCT60103 - Chemotherapy SCT60103 - Chemotherapy
SCT60103 - Chemotherapy KaiXuan Lim
 
Machine Learning in Healthcare by Mehrdad Yazdani
Machine Learning in Healthcare by Mehrdad YazdaniMachine Learning in Healthcare by Mehrdad Yazdani
Machine Learning in Healthcare by Mehrdad YazdaniData Con LA
 
Liangqun ms defense.pptx
Liangqun ms defense.pptxLiangqun ms defense.pptx
Liangqun ms defense.pptxLiangqun Lu
 
Cellular level cancer therapy
Cellular level  cancer therapyCellular level  cancer therapy
Cellular level cancer therapySuganyaPaulraj
 
Genes and Tissue Culture Assignment Presentation (Group 3)
Genes and Tissue Culture Assignment Presentation (Group 3)Genes and Tissue Culture Assignment Presentation (Group 3)
Genes and Tissue Culture Assignment Presentation (Group 3)Lim Ke Wen
 
2015 Gupta Ellison Integrative Bio (2)
2015 Gupta Ellison Integrative Bio (2)2015 Gupta Ellison Integrative Bio (2)
2015 Gupta Ellison Integrative Bio (2)Dr David Ellison
 
CCRC Clonality Poster
CCRC Clonality PosterCCRC Clonality Poster
CCRC Clonality PosterNathan How
 

What's hot (20)

SCT60103 Group 2 Presentation
SCT60103 Group 2 PresentationSCT60103 Group 2 Presentation
SCT60103 Group 2 Presentation
 
Compartment specific micro rna expression profiles (poster) poster
Compartment specific micro rna expression profiles (poster) posterCompartment specific micro rna expression profiles (poster) poster
Compartment specific micro rna expression profiles (poster) poster
 
American gut microbiome-2
American gut microbiome-2American gut microbiome-2
American gut microbiome-2
 
Tradus de onisim
 Tradus de onisim Tradus de onisim
Tradus de onisim
 
Introduction to cancer bioinformatics
Introduction to cancer bioinformaticsIntroduction to cancer bioinformatics
Introduction to cancer bioinformatics
 
Availability of Morphologically Similar, Genetically Diverge Penaeus Monodon ...
Availability of Morphologically Similar, Genetically Diverge Penaeus Monodon ...Availability of Morphologically Similar, Genetically Diverge Penaeus Monodon ...
Availability of Morphologically Similar, Genetically Diverge Penaeus Monodon ...
 
Gtc presentation
Gtc presentationGtc presentation
Gtc presentation
 
biochem of cancer modified dialysis treatment
biochem of cancer modified dialysis treatmentbiochem of cancer modified dialysis treatment
biochem of cancer modified dialysis treatment
 
Animal models in developmental therapeitocs
Animal models in developmental therapeitocsAnimal models in developmental therapeitocs
Animal models in developmental therapeitocs
 
Role of biotechnology in cancer control
Role of biotechnology in cancer controlRole of biotechnology in cancer control
Role of biotechnology in cancer control
 
Dieter Egli, "Towards Clinical Use of Mitochondrial Replacement"
Dieter Egli, "Towards Clinical Use of Mitochondrial Replacement"Dieter Egli, "Towards Clinical Use of Mitochondrial Replacement"
Dieter Egli, "Towards Clinical Use of Mitochondrial Replacement"
 
SCT60103 - Chemotherapy
SCT60103 - Chemotherapy SCT60103 - Chemotherapy
SCT60103 - Chemotherapy
 
Eli Y. Adashi, "Mitochondrial Replacement Therapy: Considering the Future of ...
Eli Y. Adashi, "Mitochondrial Replacement Therapy: Considering the Future of ...Eli Y. Adashi, "Mitochondrial Replacement Therapy: Considering the Future of ...
Eli Y. Adashi, "Mitochondrial Replacement Therapy: Considering the Future of ...
 
Machine Learning in Healthcare by Mehrdad Yazdani
Machine Learning in Healthcare by Mehrdad YazdaniMachine Learning in Healthcare by Mehrdad Yazdani
Machine Learning in Healthcare by Mehrdad Yazdani
 
Single cell pcr
Single cell pcrSingle cell pcr
Single cell pcr
 
Liangqun ms defense.pptx
Liangqun ms defense.pptxLiangqun ms defense.pptx
Liangqun ms defense.pptx
 
Cellular level cancer therapy
Cellular level  cancer therapyCellular level  cancer therapy
Cellular level cancer therapy
 
Genes and Tissue Culture Assignment Presentation (Group 3)
Genes and Tissue Culture Assignment Presentation (Group 3)Genes and Tissue Culture Assignment Presentation (Group 3)
Genes and Tissue Culture Assignment Presentation (Group 3)
 
2015 Gupta Ellison Integrative Bio (2)
2015 Gupta Ellison Integrative Bio (2)2015 Gupta Ellison Integrative Bio (2)
2015 Gupta Ellison Integrative Bio (2)
 
CCRC Clonality Poster
CCRC Clonality PosterCCRC Clonality Poster
CCRC Clonality Poster
 

Similar to ACES-bulletpoint2

2D CAT Based Modeling of Tumour Growth and Drug Transport
2D CAT Based Modeling of Tumour Growth and Drug Transport2D CAT Based Modeling of Tumour Growth and Drug Transport
2D CAT Based Modeling of Tumour Growth and Drug TransportEditor IJMTER
 
SP2016 Poster with Alan
SP2016 Poster with AlanSP2016 Poster with Alan
SP2016 Poster with AlanAlan Soetikno
 
Analyzing the Human Gut Microbiome Dynamics in Health and Disease Using Super...
Analyzing the Human Gut Microbiome Dynamics in Health and Disease Using Super...Analyzing the Human Gut Microbiome Dynamics in Health and Disease Using Super...
Analyzing the Human Gut Microbiome Dynamics in Health and Disease Using Super...Larry Smarr
 
Analyzing the Human Gut Microbiome Dynamics in Health and Disease Using Super...
Analyzing the Human Gut Microbiome Dynamics in Health and Disease Using Super...Analyzing the Human Gut Microbiome Dynamics in Health and Disease Using Super...
Analyzing the Human Gut Microbiome Dynamics in Health and Disease Using Super...Larry Smarr
 
Disseminated Breast Cancer Cells Acquire a Highly Malignant and Aggressive Me...
Disseminated Breast Cancer Cells Acquire a Highly Malignant and Aggressive Me...Disseminated Breast Cancer Cells Acquire a Highly Malignant and Aggressive Me...
Disseminated Breast Cancer Cells Acquire a Highly Malignant and Aggressive Me...Carolyn Marsden
 
Array_nmeth.3507
Array_nmeth.3507Array_nmeth.3507
Array_nmeth.3507Aana Hahn
 
A physical sciences network characterization of non-tumorigenic and metastati...
A physical sciences network characterization of non-tumorigenic and metastati...A physical sciences network characterization of non-tumorigenic and metastati...
A physical sciences network characterization of non-tumorigenic and metastati...Shashaanka Ashili
 
Capturing the Interactive Dynamics of the Human Host/Microbiome System
Capturing the Interactive Dynamics of the Human Host/Microbiome SystemCapturing the Interactive Dynamics of the Human Host/Microbiome System
Capturing the Interactive Dynamics of the Human Host/Microbiome SystemLarry Smarr
 
IMMUNOHISTOCHEMICAL ALTERATIONS IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED ...
IMMUNOHISTOCHEMICAL ALTERATIONS IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED ...IMMUNOHISTOCHEMICAL ALTERATIONS IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED ...
IMMUNOHISTOCHEMICAL ALTERATIONS IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED ...Jing Zang
 
3D In Vitro Model for Drug Efficiency Testing
3D In Vitro Model for Drug Efficiency Testing3D In Vitro Model for Drug Efficiency Testing
3D In Vitro Model for Drug Efficiency Testingjudoublen
 
Exploring the Dynamics of The Microbiome in Health and Disease
Exploring the Dynamics of The Microbiome in Health and DiseaseExploring the Dynamics of The Microbiome in Health and Disease
Exploring the Dynamics of The Microbiome in Health and DiseaseLarry Smarr
 
Development and Validation of a Nomogram for Predicting Response to Neoadjuva...
Development and Validation of a Nomogram for Predicting Response to Neoadjuva...Development and Validation of a Nomogram for Predicting Response to Neoadjuva...
Development and Validation of a Nomogram for Predicting Response to Neoadjuva...semualkaira
 
Cancer Precision Medicine Physiological Function of C MYC as Targeted Molecule
Cancer Precision Medicine Physiological Function of C MYC as Targeted MoleculeCancer Precision Medicine Physiological Function of C MYC as Targeted Molecule
Cancer Precision Medicine Physiological Function of C MYC as Targeted Moleculeijtsrd
 

Similar to ACES-bulletpoint2 (20)

2D CAT Based Modeling of Tumour Growth and Drug Transport
2D CAT Based Modeling of Tumour Growth and Drug Transport2D CAT Based Modeling of Tumour Growth and Drug Transport
2D CAT Based Modeling of Tumour Growth and Drug Transport
 
Application Brief - Breast Cancer Research
Application Brief - Breast Cancer ResearchApplication Brief - Breast Cancer Research
Application Brief - Breast Cancer Research
 
ASCB 2014 poster
ASCB 2014  posterASCB 2014  poster
ASCB 2014 poster
 
Application Brief - Breast Cancer Research
Application Brief - Breast Cancer ResearchApplication Brief - Breast Cancer Research
Application Brief - Breast Cancer Research
 
SP2016 Poster with Alan
SP2016 Poster with AlanSP2016 Poster with Alan
SP2016 Poster with Alan
 
LRP research plan final
LRP research plan finalLRP research plan final
LRP research plan final
 
Biochem Soc report
Biochem Soc reportBiochem Soc report
Biochem Soc report
 
Analyzing the Human Gut Microbiome Dynamics in Health and Disease Using Super...
Analyzing the Human Gut Microbiome Dynamics in Health and Disease Using Super...Analyzing the Human Gut Microbiome Dynamics in Health and Disease Using Super...
Analyzing the Human Gut Microbiome Dynamics in Health and Disease Using Super...
 
Analyzing the Human Gut Microbiome Dynamics in Health and Disease Using Super...
Analyzing the Human Gut Microbiome Dynamics in Health and Disease Using Super...Analyzing the Human Gut Microbiome Dynamics in Health and Disease Using Super...
Analyzing the Human Gut Microbiome Dynamics in Health and Disease Using Super...
 
Selfseedposter mss2013
Selfseedposter mss2013Selfseedposter mss2013
Selfseedposter mss2013
 
FRD Grant Paper
FRD Grant PaperFRD Grant Paper
FRD Grant Paper
 
Disseminated Breast Cancer Cells Acquire a Highly Malignant and Aggressive Me...
Disseminated Breast Cancer Cells Acquire a Highly Malignant and Aggressive Me...Disseminated Breast Cancer Cells Acquire a Highly Malignant and Aggressive Me...
Disseminated Breast Cancer Cells Acquire a Highly Malignant and Aggressive Me...
 
Array_nmeth.3507
Array_nmeth.3507Array_nmeth.3507
Array_nmeth.3507
 
A physical sciences network characterization of non-tumorigenic and metastati...
A physical sciences network characterization of non-tumorigenic and metastati...A physical sciences network characterization of non-tumorigenic and metastati...
A physical sciences network characterization of non-tumorigenic and metastati...
 
Capturing the Interactive Dynamics of the Human Host/Microbiome System
Capturing the Interactive Dynamics of the Human Host/Microbiome SystemCapturing the Interactive Dynamics of the Human Host/Microbiome System
Capturing the Interactive Dynamics of the Human Host/Microbiome System
 
IMMUNOHISTOCHEMICAL ALTERATIONS IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED ...
IMMUNOHISTOCHEMICAL ALTERATIONS IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED ...IMMUNOHISTOCHEMICAL ALTERATIONS IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED ...
IMMUNOHISTOCHEMICAL ALTERATIONS IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED ...
 
3D In Vitro Model for Drug Efficiency Testing
3D In Vitro Model for Drug Efficiency Testing3D In Vitro Model for Drug Efficiency Testing
3D In Vitro Model for Drug Efficiency Testing
 
Exploring the Dynamics of The Microbiome in Health and Disease
Exploring the Dynamics of The Microbiome in Health and DiseaseExploring the Dynamics of The Microbiome in Health and Disease
Exploring the Dynamics of The Microbiome in Health and Disease
 
Development and Validation of a Nomogram for Predicting Response to Neoadjuva...
Development and Validation of a Nomogram for Predicting Response to Neoadjuva...Development and Validation of a Nomogram for Predicting Response to Neoadjuva...
Development and Validation of a Nomogram for Predicting Response to Neoadjuva...
 
Cancer Precision Medicine Physiological Function of C MYC as Targeted Molecule
Cancer Precision Medicine Physiological Function of C MYC as Targeted MoleculeCancer Precision Medicine Physiological Function of C MYC as Targeted Molecule
Cancer Precision Medicine Physiological Function of C MYC as Targeted Molecule
 

ACES-bulletpoint2

  • 1. RESULTS Demonstrate Quantification of Cell Movement Comparing images, the distance of the leading cell in each channel from the cell reservoir was measured (Figure 3).  No cell response observed in standard media.  Some migration observed in cells with conditioned media (Figure 4).  Highest migration observed with the reagent side containing conditioned media. Results indicated that the media conditioned with SaOs-2 acted as a chemoattractant (Figure 5). sylvia.loh@mavs.uta.edu ABSTRACT Monitoring the migration of cancer cells, metastasis can be better understood using microfluidics.  Metastasis of cancer is organ specific:  Prostate cancer moves to the bone and lungs.  Breast cancer moves to the bone. In this work, we assess the impact of conditioned media on cell migration as a model for metastasis of cancer. INTRODUCTION The American Cancer Society estimated:  1 in 6 men will develop prostate cancer.  1 in 8 women will develop breast cancer. Microfluidics provide a(n):  Ability to monitor cells.  Accurate quantification of cell migration.  Microenvironment for precise gradients. MATERIALS AND METHODS  Fabricated with poly-dimethylsiloxane (PDMS).  Consisted of a cell and a reagent reservoir.  Ten microchannels (10 μm in height, 25 μm in width and 1,000 μm in length) connected the reservoirs.  Contained 32 devices (Figure 1). EXPERIMENT SETTING  Prostate cancer (PC-3) cells were transfected with green fluorescent protein (Figure 2).  The cells were cultured with standard RPMI or conditioned media from SaOs-2 cells.  Cells were seeded in cell reservoir at 3×103 in 50 μL of media and incubated.  Equal volume of reagent was added to the other reservoir.  Images were captured at designated 24 hour intervals using a Nikon Ti Eclipse microscope. Microfluidics: An innovative approach in Monitoring Cancer Metastasis Sylvia Loh, Junior, Biology/Bioengineering Advisors: Smitha Rao and J. –C. Chiao SUMMARY Microfluidic Devices for Cell Migration  Physical confinement to cells at a micro- scale level for the movement.  Controllable microenvironment for chemogradients, time, and temperature.  Allows recovery of cells for downstream analyses.  Validating the results and collecting quantitative data.  Work in Progress. Figure 1: Microfluidic device mounted on a culture plate A B C D ACKNOWLEDGEMENTS This work was supported by National Institutes of Health (NIH) National Cancer Institute grant R15CA133623, North Texas Cancer Research Foundation and TxMRC. Figure 2: PC3 cells transfected with GFP (green fluorescent protein) in a cell reservoir under Brightfield microscope and ultraviolet light Brightfield UV Figure 4: Microchannels containing cells with conditioned media, showing migration Figure 5: Measurement of migration of PC-3 cells with and without SaOs-2 conditioned media against standard media or SaOs-2 conditioned media 0 2 4 6 8 10 12 14 16 18 Media vs. Media Media vs. Conditioned Conditioned vs. Media Conditioned vs. Conditioned Migrationdistance(μm) Day 1 Day 2 Day 3 Day 4 Day 5 Figure 3: Migration of a PC-3 cell in RPMI in a single channel over a 5 day period with SaOs2 conditioned media as attraction Day 1 - 31.39 μm Day 2 - 203.16 μm Day 3 - 283.51 μm Day 4 - 285.37 μm Day 5 - 290.05 μm